These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8430921)

  • 1. Behavioral and cognitive effect of theophylline: a dose-response study.
    Stein MA; Lerner CA
    Ann Allergy; 1993 Feb; 70(2):135-40. PubMed ID: 8430921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartame, behavior, and cognitive function in children with attention deficit disorder.
    Shaywitz BA; Sullivan CM; Anderson GM; Gillespie SM; Sullivan B; Shaywitz SE
    Pediatrics; 1994 Jan; 93(1):70-5. PubMed ID: 7505423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the effects of treatment with theophylline on the cognitive process and behaviour of children with bronchial asthma.
    Gil CA; Silveira ML; Soares FJ; Solé D; Naspitz C
    Allergol Immunopathol (Madr); 1993; 21(5):204-6. PubMed ID: 8160567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate dosing: twice daily versus three times daily.
    Stein MA; Blondis TA; Schnitzler ER; O'Brien T; Fishkin J; Blackwell B; Szumowski E; Roizen NJ
    Pediatrics; 1996 Oct; 98(4 Pt 1):748-56. PubMed ID: 8885956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior abnormalities and poor school performance due to oral theophylline use.
    Rachelefsky GS; Wo J; Adelson J; Mickey MR; Spector SL; Katz RM; Siegel SC; Rohr AS
    Pediatrics; 1986 Dec; 78(6):1133-8. PubMed ID: 3786037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved behavior and sleep after adenotonsillectomy in children with sleep-disordered breathing.
    Wei JL; Mayo MS; Smith HJ; Reese M; Weatherly RA
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):974-9. PubMed ID: 17938319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
    J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential evaluation of behavioral treatments and methylphenidate dosage for children with attention deficit hyperactivity disorder.
    Gulley V; Northup J; Hupp S; Spera S; LeVelle J; Ridgway A
    J Appl Behav Anal; 2003; 36(3):375-8. PubMed ID: 14596580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methylphenidate on the cognitive and personality functioning of ADHD children.
    Lufi D; Parish-Plass J; Gai E
    Isr J Psychiatry Relat Sci; 1997; 34(3):200-9. PubMed ID: 9334525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a statistical approach to classifying treatment response in individual children with ADHD.
    Mollica CM; Maruff P; Vance A
    Hum Psychopharmacol; 2004 Oct; 19(7):445-56. PubMed ID: 15378673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
    Voigt RG; Llorente AM; Jensen CL; Fraley JK; Berretta MC; Heird WC
    J Pediatr; 2001 Aug; 139(2):189-96. PubMed ID: 11487742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disentangling the relation between television viewing and cognitive processes in children with attention-deficit/hyperactivity disorder and comparison children.
    Acevedo-Polakovich ID; Lorch EP; Milich R; Ashby RD
    Arch Pediatr Adolesc Med; 2006 Apr; 160(4):354-60. PubMed ID: 16585479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron and zinc supplementation does not improve parent or teacher ratings of behavior in first grade Mexican children exposed to lead.
    Kordas K; Stoltzfus RJ; López P; Rico JA; Rosado JL
    J Pediatr; 2005 Nov; 147(5):632-9. PubMed ID: 16291354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
    Mulhern RK; Khan RB; Kaplan S; Helton S; Christensen R; Bonner M; Brown R; Xiong X; Wu S; Gururangan S; Reddick WE
    J Clin Oncol; 2004 Dec; 22(23):4795-803. PubMed ID: 15570081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine.
    Stein MA; Krasowski M; Leventhal BL; Phillips W; Bender BG
    Arch Pediatr Adolesc Med; 1996 Mar; 150(3):284-8. PubMed ID: 8603222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder.
    Bilici M; Yildirim F; Kandil S; Bekaroğlu M; Yildirmiş S; Değer O; Ulgen M; Yildiran A; Aksu H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):181-90. PubMed ID: 14687872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.